Cancer Signal Detected with a Cancer Signal Origin of Head and Neck Cancer
“You have a squamous cell carcinoma and oropharyngeal type of cancer.”- Byrce’s doctor
Bryce’s Experience with the Galleri test
[Bryce] My name is Bryce, and this is my story with Galleri.
Spent over 25 years active and in the military reserve, and I was very thankful to serve with the Force Reconnaissance Marines.
I was exposed to a chemical when I was stationed at Camp Lejeune, North Carolina. Years ago, I really wasn’t concerned about it, thinking, well, they’re just being precautionary. But after hearing other stories, one guy in my platoon is passed on from a cancer. I’m like, “Holy cow, this is real.” And knew that I needed to get tested at some point.
Came across some literature on Galleri. The Galleri test can screen for many of the deadliest forms of cancer. I said,
After having my blood drawn, about two weeks later, I found out that I had a Cancer Signal Detected for head and neck cancer.
And so I immediately contacted my physician and we discussed further steps. After further screening and PET scans, CT scans, the doctor came back and said, "You have a squamous cell carcinoma and oropharyngeal type of cancer."
And thankful that where mine was caught and I could be treated. And so far I’m doing well. I’m very thankful. I’m happy to be alive.
I just did my annual physicals and I’m thinking that, well, if I have a symptom, I’ll see it. And the doctor, he’ll see it. But that wasn’t the case. The doctor didn’t see anything on me. And he was very surprised when I came back. He was like,
It hits home when you hear the term cancer. How much longer do I have to live?
You don’t know if you could get yourself treated and knowing that you don’t have cancer anymore.
I’m thankful.
Based on a clinical study of people ages 50 to 79 around 1% are expected to receive a Cancer Signal Detected result, which includes a predicted Cancer Signal Origin. After diagnostic evaluation, around 62% of these people are expected to have a confirmed cancer diagnosis.
The overall sensitivity in study participants with liver/bile duct cancer was 93.5% (100% for stage I, 70.0% stage II, 100% stage III, 100% stage IV).
The Galleri test is recommended for use in adults with an elevated risk for cancer, such as those age 50 or older. The test does not detect all cancers and should be used in addition to routine cancer screening tests recommended by a healthcare provider. The Galleri test is intended to detect cancer signals and predict where in the body the cancer signal is located. Use of the test is not recommended in individuals who are pregnant, 21 years old or younger, or undergoing active cancer treatment.
Results should be interpreted by a healthcare provider in the context of medical history, clinical signs, and symptoms. A test result of No Cancer Signal Detected does not rule out cancer. A test result of Cancer Signal Detected requires confirmatory diagnostic evaluation by medically established procedures (e.g., imaging) to confirm cancer.
If cancer is not confirmed with further testing, it could mean that cancer is not present or testing was insufficient to detect cancer, including due to the cancer being located in a different part of the body. False positive (a cancer signal detected when cancer is not present) and false negative (a cancer signal not detected when cancer is present) test results do occur. Rx only.
The GRAIL clinical laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) and accredited by the College of American Pathologists. The Galleri test was developed — and its performance characteristics were determined — by GRAIL. The Galleri test has not been cleared or approved by the Food and Drug Administration. The GRAIL clinical laboratory is regulated under CLIA to perform high-complexity testing. The Galleri test is intended for clinical purposes
Have more questions?
Please answer the following questions to fill in the appropriate form.
GRAIL Customer Service
(833) 694‑2553
customerservice@grail.com
To report suspected Adverse Events or product issues, contact GRAIL Customer Service.
-
What describes you best?
-
What are you looking for?
-
Fill in the form
By submitting this form, you agree to GRAIL’s use of this information to contact you, including for marketing purposes. Please do not include any sensitive or confidential information, including health information. For more information, please refer to our privacy notice.
Billing Support
By submitting this form, you agree to GRAIL’s use of this information to contact you. Please do not include any sensitive or confidential information, including health information. For more information, please refer to our privacy notice.
By submitting this form, you agree to GRAIL’s use of this information to contact you, including for marketing purposes. Please do not include any sensitive or confidential information, including health information. For more information, please refer to our privacy notice.
By submitting this form, you agree to GRAIL’s use of this information to contact you, including for marketing purposes. Please do not include any sensitive or confidential information, including health information. For more information, please refer to our privacy notice.
By submitting this form, you agree to GRAIL’s use of this information to contact you, including for marketing purposes. Please do not include any sensitive or confidential information, including health information. For more information, please refer to our privacy notice.
By submitting this form, you agree to GRAIL’s use of this information to contact you, including for marketing purposes. Please do not include any sensitive or confidential information, including health information. For more information, please refer to our privacy notice.
By submitting this form, you agree to GRAIL’s use of this information to contact you, including for marketing purposes. Please do not include any sensitive or confidential information, including health information. For more information, please refer to our privacy notice.
Health System or Provider Network
By submitting this form, you agree to GRAIL’s use of this information to contact you, including for marketing purposes. Please do not include any sensitive or confidential information, including health information. For more information, please refer to our privacy notice.
Do you represent a first responder or firefighter organization? Use this form instead.
By submitting this form, you agree to GRAIL’s use of this information to contact you, including for marketing purposes. Please do not include any sensitive or confidential information, including health information. For more information, please refer to our privacy notice.
By submitting this form, you agree to GRAIL’s use of this information to contact you, including for marketing purposes. Please do not include any sensitive or confidential information, including health information. For more information, please refer to our privacy notice.
Fill out the form to download a copy of the full case study.
By submitting this form, you agree to GRAIL’s use of this information to contact you, including for marketing purposes. Please do not include any sensitive or confidential information, including health information. For more information, please refer to our privacy notice.